Lexie B3 vs RCA In-Ear

The Lexie B3 is a behind-the-ear OTC hearing aid priced at $999 that earns an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #1 among the 65 OTC hearing aids we've evaluated, making it a standout performer in its category. In our standardized testing, the Lexie B3 demonstrates excellent speech-in-quiet performance at 4.5/5, scoring 1.73 points above the OTC category average of 2.79/5. Speech-in-noise results are more nuanced—while the 2.5/5 score sits 1.02 points above the category average of 1.48/5, this remains mixed in absolute terms. Music streaming quality is solid at 3.3/5, exceeding the category average by 1.38 points, and feedback handling is excellent at 4.6/5. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above the category average. The device uses a tulip dome coupling in both initial and tuned configurations, maintaining consistent performance across fitting conditions with identical normalized scores of 4.8/5 for both fits. For those considering alternatives, devices like the RxEars Rxi, Meta Ray-Ban Glasses (Gen 2), and Cearvol Wave offer lower price points, though with correspondingly lower SoundScores. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance who prioritize speech clarity in quieter environments and quality music streaming, and who can accommodate its mid-tier OTC price point.

The RCA In-Ear is a budget OTC hearing aid priced at $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC category at #64 of 65 devices tested. Speech performance is a significant weakness for this device. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, while speech in noise also scores 1.0/5, sitting 0.48 points below average. These low absolute scores indicate limited benefit for understanding conversation in most listening situations. Music streaming scored 0.0/5, measuring 1.92 points below the category average—this device is not suitable for audio entertainment. The RCA In-Ear does show strength in feedback handling, scoring an excellent 5.0/5, which is 0.46 points above the category average. Own-voice comfort is mixed at 2.6/5, essentially matching the category average with only a 0.09-point advantage. The rechargeable battery design offers convenience for daily use. At this price point, consumers have substantially higher-performing alternatives. Devices like the Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and several others in the same budget range deliver meaningfully better speech clarity and overall sound quality. The RCA In-Ear may appeal to those prioritizing feedback-free operation above all else, but most users seeking improved hearing will find better value elsewhere in the OTC market.